These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 34734816)

  • 1. Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway.
    Dindaş F; Güngör H; Ekici M; Akokay P; Erhan F; Doğduş M; Yılmaz MB
    Anatol J Cardiol; 2021 Nov; 25(11):821-828. PubMed ID: 34734816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα-mTORC1 signaling pathway.
    Hu F; Yan S; Lin L; Qiu X; Lin X; Wang W
    Mol Cell Biochem; 2024 Sep; ():. PubMed ID: 39304614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacubitril/valsartan alleviates sepsis-induced myocardial injury in rats via dual angiotensin receptor-neprilysin inhibition and modulation of inflammasome/caspase 1/IL1β pathway.
    Refaie MMM; El-Hussieny M; Bayoumi AMA; Abdelraheem WM; Abdel-Hakeem EA; Shehata S
    Eur J Pharmacol; 2024 Sep; 979():176834. PubMed ID: 39038638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity.
    Boutagy NE; Feher A; Pfau D; Liu Z; Guerrera NM; Freeburg LA; Womack SJ; Hoenes AC; Zeiss C; Young LH; Spinale FG; Sinusas AJ
    JACC CardioOncol; 2020 Dec; 2(5):774-787. PubMed ID: 33437965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in
    Myakala K; Jones BA; Wang XX; Levi M
    Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1133-F1151. PubMed ID: 33870733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway.
    Refaie MMM; Amin EF; Hassan MN; Rifaai RA; Bayoumi AMA; Kamel MY
    J Pharm Pharmacol; 2024 Jul; 76(7):788-797. PubMed ID: 38538077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Melatonin and Adrenomedullin in Reducing the Cardiotoxic Effects of Doxorubicin in Rats.
    Durdagi G; Pehlivan DY; Oyar EO; Bahceci SA; Ozbek M
    Cardiovasc Toxicol; 2021 May; 21(5):354-364. PubMed ID: 33389601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.
    Shaker RA; Abboud SH; Assad HC; Hadi N
    BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness.
    Aroor AR; Mummidi S; Lopez-Alvarenga JC; Das N; Habibi J; Jia G; Lastra G; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2021 Apr; 20(1):80. PubMed ID: 33882908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis.
    Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L
    Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacubitril/valsartan reduces endoplasmic reticulum stress in a rat model of doxorubicin-induced cardiotoxicity.
    Kim BS; Park IH; Lee AH; Kim HJ; Lim YH; Shin JH
    Arch Toxicol; 2022 Apr; 96(4):1065-1074. PubMed ID: 35152301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats.
    Li Q; Fang Y; Peng DW; Li LA; Deng CY; Yang H; Kuang SJ; Li QQ; Zhang MZ; Zeng P; Zhang QH; Liu Y; Deng H; Wei W; Xue YM; Wu SL; Rao F
    Eur J Pharmacol; 2023 Aug; 952():175754. PubMed ID: 37182595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways.
    Mahmoud Refaie MM; Ahmed Rifaai R; Bayoumi AMA; Shehata S
    J Pharm Pharmacol; 2023 Sep; 75(9):1237-1248. PubMed ID: 37262315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-α.
    Ma T; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
    Mol Biol Rep; 2019 Feb; 46(1):105-118. PubMed ID: 30362071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.
    Habibi J; Aroor AR; Das NA; Manrique-Acevedo CM; Johnson MS; Hayden MR; Nistala R; Wiedmeyer C; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2019 Mar; 18(1):40. PubMed ID: 30909895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of valsartan against doxorubicin-induced cardiotoxicity: Histopathology and metabolomics in vivo study.
    Alhazzani K; Alotaibi MR; Alotaibi FN; Aljerian K; As Sobeai HM; Alhoshani AR; Alanazi AZ; Alanazi WA; Alswayyed M
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22842. PubMed ID: 34273911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.
    Sung PH; Chai HT; Yang CC; Chiang JY; Chen CH; Chen YL; Yip HK
    Biomed Pharmacother; 2022 Apr; 148():112745. PubMed ID: 35202913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant and antiapoptotic effects of sea cucumber and valsartan against doxorubicin-induced cardiotoxicity in rats: The role of low dose gamma irradiation.
    Ibrahim DM; Radwan RR; Abdel Fattah SM
    J Photochem Photobiol B; 2017 May; 170():70-78. PubMed ID: 28395211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
    Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
    Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a.
    Sun Z; Yan B; Yu WY; Yao X; Ma X; Sheng G; Ma Q
    Exp Ther Med; 2016 Sep; 12(3):1879-1884. PubMed ID: 27588105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.